Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Obesity 1Metabolic Syndrome 1Hyperandrogenism 1Cardiovascular Diseases 1

Interventions

Metformin 4Magnetic Resonance Spectroscopy 2Exercise 2Ethinyl Estradiol 2drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Sugars 1Spironolactone 1Preoperative Exercise 1Phlebotomy 1Pancreaticoduodenectomy 1Inositol 1Hepatectomy 1Flutamide 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1Cyproterone Acetate 1Caloric Restriction 1Bloodletting 1Blood Pressure 1Blood Donation 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Metabolic Syndrome × Spironolactone × Clear all
NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

University Magna Graecia

Phase NA Completed
56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡